Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG
Clinical trial NCT00037713 · COMPLETED
Trial details
- NCT number
- NCT00037713
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1998-09-01
- Primary completion
- 2002-10-01
- Enrollment
- 515
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.